FdaApplication
NDA 217064
Identifiers
- fda_app_no: NDA217064
Properties
| Property | Value |
|---|---|
| applicant_name | FAMYGEN LIFE SCIENCES INC |
| application_type | NDA |
| approval_date | 2023-09-25 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| RYZUMVI | PHENTOLAMINE MESYLATE | EQ 0.75% BASE | SOLUTION;OPHTHALMIC |
1 product